Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Therefore, this study will aim to assess the effectiveness and tolerability of the on-demand use of combined dapoxetine with tadalafil and combined dapoxetine with lidocaine 5% spray in treatment of patients with lifelong premature ejaculation and non-responding to dapoxetine alone.
This study will be carried out on 60 patients with lifelong premature ejaculation and non-responding to dapoxetine alone.
All patients will be equally divided into 2 groups (30 patients each). Group 1 was given on-demand 30 mg dapoxetine and 10 mg tadalafil 1 h before intercourse. Group 1 was given on-demand 30 mg dapoxetine 1 h before intercourse and apply lidocaine 5% spray on the glans penis 10 minutes the wash before intercourse.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Patients with lifelong premature ejaculation and non-responding to dapoxetine alone | Active Comparator | Group 1 was given on-demand 30 mg dapoxetine and 10 mg tadalafil 1 h before intercourse. |
|
| Patients with Lifelong Premature Ejaculation and Non-responding to Dapoxetine Alone. | Active Comparator | Group 2 was given on-demand 30 mg dapoxetine 1 h before intercourse and apply lidocaine 5% spray on the glans penis 10 minutes the wash before intercourse. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Tadalafil and Combined Dapoxietine | Drug | Group 1 was given on-demand 30 mg dapoxetine and 10 mg tadalafil 1 h before intercourse. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Intravaginal ejaculatory latency time (IELT) | 0-8 weeks | |
| Arabic Index of Premature Ejaculation (AIPE) | 0-8 week |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Male Patients with PE
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Mohammed A Abu El-Hamd, MD | Contact | 01004139060 | Mohammedadva@yahoo.com | |
| Mohammed Abu El-Hamd, MD | Contact | 01004139060 | Mohammedadva@yahoo.com |
| Name | Affiliation | Role |
|---|---|---|
| Mohammed A El-Hamd | Dermatology, Venereology and Andrology, Faculty of Medicine, Sohag University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Mohammed Abu El-Hamd | Recruiting | Sohag | 82524 | Egypt |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
All patients will be equally divided into 2 groups (30 patients each). Group 1 was given on-demand 30 mg dapoxetine and 10 mg tadalafil 1 h before intercourse. Group 1 was given on-demand 30 mg dapoxetine 1 h before intercourse and apply lidocaine 5% spray on the glans penis 10 minutes the wash before intercourse.
Not provided
Not provided
All patients will be equally divided into 2 groups (30 patients each).Group 1 was given on-demand 30 mg dapoxetine and 10 mg tadalafil 1 h before intercourse. Group 1 was given on-demand 30 mg dapoxetine 1 h before intercourse and apply lidocaine 5% spray on the glans penis 10 minutes the wash before intercourse.
|
| Dapoxietine and Combined Lidocaine 5% Spray | Drug | Group 2 was given on-demand 30 mg dapoxetine 1 h before intercourse and apply lidocaine 5% spray on the glans penis 10 minutes the wash before intercourse. |
|
|
| ID | Term |
|---|---|
| D061686 | Premature Ejaculation |
| ID | Term |
|---|---|
| D000097910 | Ejaculatory Dysfunction |
| D005832 | Genital Diseases, Male |
| D000091662 | Genital Diseases |
| D000091642 | Urogenital Diseases |
| D012735 | Sexual Dysfunction, Physiological |
| D052801 | Male Urogenital Diseases |
| D020018 | Sexual Dysfunctions, Psychological |
| D001523 | Mental Disorders |
Not provided
Not provided
| ID | Term |
|---|---|
| D000068581 | Tadalafil |
| D008012 | Lidocaine |
| ID | Term |
|---|---|
| D002243 | Carbolines |
| D011725 | Pyridines |
| D006573 | Heterocyclic Compounds, 1-Ring |
| D006571 | Heterocyclic Compounds |
| D026121 | Indole Alkaloids |
| D007211 | Indoles |
| D006574 | Heterocyclic Compounds, 2-Ring |
| D000072471 | Heterocyclic Compounds, Fused-Ring |
| D006575 | Heterocyclic Compounds, 3-Ring |
| D000083 | Acetanilides |
| D000813 | Anilides |
| D000577 | Amides |
| D009930 | Organic Chemicals |
| D000814 | Aniline Compounds |
| D000588 | Amines |
Not provided
Not provided